Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Biolato

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Liver International : Official Journal of the International Association for the Study of the Liver|July 3, 2026
Enhanced Liver Fibrosis Test, FIB-4 and FibroScan: Real-World Prognostic Accuracy for MASLD in a Biopsy-Controlled CohortAntonio Liguori, Francesca D'Ambrosio, Giulia Angelini, et al.
Clinical Transplantation|December 2, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective studyRaffaella Lionetti, Vincenza Calvaruso, Paola Piccolo, et al.
Journal of Hepatology|August 12, 2009
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasisLuca Miele, Selenia Vallone, Consuelo Cefalo, et al.
European Radiology|September 2, 2018
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenibRoberto Iezzi, Maurizio Pompili, Emanuele Rinninella, et al.
Internal and Emergency Medicine|July 25, 2023
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 wavesLuca Miele, Marianxhela Dajko, Maria Chiara Savino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 13, 2021
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1)Luca Miele, Alessia Perna, Marianxhela Dajko, et al.
Scientific Reports|January 26, 2019
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access programVincenza Calvaruso, Chiara Mazzarelli, Laura Milazzo, et al.
World Journal of Hepatology|January 24, 2018
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinomaFrancesca Romana Ponziani, Irene Spinelli, Emanuele Rinninella, et al.
Journal of Clinical Medicine|July 13, 2024
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY StudyPaolo Gallo, Antonio De Vincentis, Francesca Terracciani, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2025
Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrencePatrizia Burra, Sara Battistella, Laura Turco, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Liver International : Official Journal of the International Association for the Study of the Liver|July 3, 2026
Enhanced Liver Fibrosis Test, FIB-4 and FibroScan: Real-World Prognostic Accuracy for MASLD in a Biopsy-Controlled CohortAntonio Liguori, Francesca D'Ambrosio, Giulia Angelini, et al.
Clinical Transplantation|December 2, 2017
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective studyRaffaella Lionetti, Vincenza Calvaruso, Paola Piccolo, et al.
Journal of Hepatology|August 12, 2009
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasisLuca Miele, Selenia Vallone, Consuelo Cefalo, et al.
European Radiology|September 2, 2018
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenibRoberto Iezzi, Maurizio Pompili, Emanuele Rinninella, et al.
Internal and Emergency Medicine|July 25, 2023
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 wavesLuca Miele, Marianxhela Dajko, Maria Chiara Savino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 13, 2021
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1)Luca Miele, Alessia Perna, Marianxhela Dajko, et al.
Scientific Reports|January 26, 2019
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access programVincenza Calvaruso, Chiara Mazzarelli, Laura Milazzo, et al.
World Journal of Hepatology|January 24, 2018
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinomaFrancesca Romana Ponziani, Irene Spinelli, Emanuele Rinninella, et al.
Journal of Clinical Medicine|July 13, 2024
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY StudyPaolo Gallo, Antonio De Vincentis, Francesca Terracciani, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2025
Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrencePatrizia Burra, Sara Battistella, Laura Turco, et al.
Pageof 6